{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:00:34Z","timestamp":1792785634596,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Royal Australian and New Zealand College of Obstetricians and Gynaecologists","id":[{"id":"https:\/\/ror.org\/03naw9h65","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003122","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003122","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ejogrb.2020.10.036","type":"journal-article","created":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T01:27:29Z","timestamp":1602984449000},"page":"105-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Day 1 to day 4 serum hCG change in predicting single-dose methotrexate treatment failure for tubal ectopic pregnancies"],"prefix":"10.1016","volume":"255","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1933-2307","authenticated-orcid":false,"given":"Amy","family":"Goh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Karine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supuni","family":"Kapurubandara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2020.10.036_bib0005","first-page":"1406","article-title":"Tubal ectopic pregnancy","volume":"02","author":"Varma","year":"2012","journal-title":"Clin Evid"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/902426","article-title":"Failure rate of single dose methotrexate in management of ectopic pregnancy","volume":"2015","author":"Sendy","year":"2015","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0015","first-page":"e15","article-title":"Diagnosis and management of ectopic pregnancy","volume":"12","author":"Elson","year":"2016","journal-title":"Brit J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0020","first-page":"1","article-title":"Ectopic pregnancy in the United States, 1970-1986","volume":"38","author":"Centers for Disease Control and Prevention","year":"1989","journal-title":"CDC Surveil Summ"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0025","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/01443615.2019.1575344","article-title":"Various BhCG monitoring protocols for predicting the success of single-dose methotrexate in the treatment of ectopic pregnancy","volume":"39","author":"Kanmaz","year":"2019","journal-title":"J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/09513590.2018.1490406","article-title":"Risk factors and human chorionic gonadotropin trends in patients with ruptured tubal ectopic pregnancies despite methotrexate treatment","volume":"35","author":"Hutchinson","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ijgo.12419","article-title":"Trends in serum human chorionic gonadotropin levels 0-4 days after methotrexate administration for predicting tubal ectopic pregnancy treatment success","volume":"141","author":"Wong","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0040","first-page":"754","article-title":"Single-dose methotrexate for treatment of ectopic pregnancy","volume":"77","author":"Stovall","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.03.022","article-title":"Are early human chorionic gonadotropin levels after methotrexate therapy a predictor of response in ectopic pregnancy?","volume":"202","author":"Nguyen","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0050","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1056\/NEJM199912233412604","article-title":"Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies","volume":"341","author":"Lipscomb","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0055","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/humrep\/del433","article-title":"A validation of the most commonly used protocol to predict the success of single-dose methotrexate in the treatment of ectopic pregnancy","volume":"22","author":"Kirk","year":"2007","journal-title":"Human Reprod"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0060","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00404-019-05068-1","article-title":"Can early bHCG change and baseline progesterone level predict treatment outcome in patients receiving single dose Methotrexate protocol for tubal ectopic pregnancy?","volume":"299","author":"Brunello","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2393-13-30","article-title":"Using a decline in serum hCG between days 0-4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study","volume":"13","author":"Skubisz","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5152\/jtgga.2013.50133","article-title":"Assessment of early decline in the percentage of \u03b2-hCG values between days 0 and 4 after methotrexate therapy in ectopic pregnancy for the prediction of treatment success","volume":"14","author":"Celik","year":"2013","journal-title":"J Turkish-German Gynecol Assoc"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0075","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejogrb.2017.06.020","article-title":"Role of day 4 HCG as an early predictor of success after methotrexate therapy for ectopic pregnancies","volume":"215","author":"Girija","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-2006-934097","article-title":"Do serum beta-human chorionic gonadotropin levels on day 4 following methotrexate treatment of patients with ectopic pregnancy predict successful single-dose therapy?","volume":"23","author":"Gabbur","year":"2006","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0085","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/ajo.12257","article-title":"McGee T. bhCG monitoring after single-dose methotrexate treatment of tubal ectopic pregnancy: is the Day 4 bhCG necessary? A retrospective cohort study","volume":"54","author":"Atkinson","year":"2014","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0090","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.fertnstert.2006.11.138","volume":"88","author":"Agostini","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0095","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s13224-014-0668-3","article-title":"Predictors of success of a single-dose methotrexate in the treatment of ectopic pregnancy","volume":"66","author":"Alsammami","year":"2016","journal-title":"J Obstet Gynaecol India"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.rbmo.2019.02.005","article-title":"Early prediction of the success of methotrexate treatment success by 24-hour pretreatment increment in HCG and day 1-4 change in HCG","volume":"39","author":"Levin","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejogrb.2018.10.046","article-title":"Significant increase in serum hCG levels following methotrexate therapy is associated with lower treatment success rates in ectopic pregnancy patients","volume":"231","author":"Mashiach","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0110","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00404-013-2879-8","article-title":"Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy","volume":"288","author":"Ustunyurt","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gyobfe.2013.08.006","article-title":"Prognostic value of early hCG changes after methotrexate injection for ectopic pregnancy","volume":"42","author":"Bottin","year":"2014","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0120","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00404-014-3593-x","article-title":"Early prediction for the requirement of second or third dose methotrexate in women with ectopic pregnancy, treated with single-dose regimen","volume":"291","author":"Yildrim","year":"2015","journal-title":"Arch Gynaecol Obstet"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0125","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejogrb.2020.02.029","article-title":"Prognostic accuracy of a novel methotrexate protocol for the resolution of tubal ectopic pregnancies","volume":"247","author":"Leonardi","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ajog.2019.01.002","article-title":"Two-dose versus single-dose methotrexate for treatment of ectopic pregnancy: a meta-analysis","volume":"221","author":"Alur-Gupta","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0135","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.mjafi.2012.08.032","article-title":"Systemic methotrexate: an effective alternative to surgery for management of unruptured ectopic pregnancy","volume":"69","author":"Talwar","year":"2013","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0140","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.20147","article-title":"Comparison of two different protocols of methotrexate therapy in medical management of ectopic pregnancy","volume":"17","author":"Saadati","year":"2015","journal-title":"Iran Red Crescent Med J"},{"issue":"590","key":"10.1016\/j.ejogrb.2020.10.036_bib0145","article-title":"Medical management of ectopic pregnancy with single-dose and 2-dose methotrexate protocols: human chorionic gonadotropin trends and patient outcomes","volume":"215","author":"Mergenthal","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0150","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0015-0282(16)60549-6","article-title":"Outpatient chemotherapy of unruptured ectopic pregnancy","volume":"51","author":"Stovall","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2020.10.036_bib0155","unstructured":"Mayo Clinic Laboratories. Beta-Human Chorionic Gonadotropin, Quantitative, Serum. Mayo Clinic Laboratories Neurology Testing Catalog. [Cited 2020 Jun 20]. Available from: https:\/\/neurology.testcatalog.org\/show\/BHCG."}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520306746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211520306746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:49:18Z","timestamp":1759556958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211520306746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":31,"alternative-id":["S0301211520306746"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.10.036","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Day 1 to day 4 serum hCG change in predicting single-dose methotrexate treatment failure for tubal ectopic pregnancies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2020.10.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}